Metrics as of 10/15/2026, 11:23 AM (Berlin time), refresh in progress.
Medifast Stock
Medifast, Inc.
Company data
- Sector
- Consumer Cyclical
- Industry
- Personal Products & Services
- Country
- United States
- CEO
- Nicholas Johnson
- Employees
- 380
- Market cap
- $132 M
- IPO
- 30/12/1993
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack…
Medifast stock: price history
1D
+1.5%
1W
+3.6%
1M
-1.3%
6M
+9.2%
YTD
+11.0%
1Y
-10.7%
2Y
-31.7%
5Y
-93.8%
10Y
-70.3%
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~59% stronger price swings than usual
Ask the agents about Medifast
Analyst assessment of Medifast
PRICE TARGET LOW
US$12.00
CONSENSUS
US$59.67
MEDIAN
US$17.00
PRICE TARGET HIGH
US$150.00
0
STRONG BUY
4
BUY
6
HOLD
2
SELL
0
STRONG SELL
12
TOTAL · Hold
As of: 19/02/2026
Medifast stock metrics
P/E
-5.09
P/B
0.67
EV/EBITDA
-705.59
RETURN ON EQUITY
-1.6%
NET MARGIN
-4.1%
DEBT/EQUITY
0.14
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
75.7%
FLOAT SHARES
8,458,713
AVG. DAILY VOLUME (30D)
113,593
Insider transactions (SEC)
Chard Daniel R
Chard Daniel R
Kiai Parsa
Kiai Parsa
Kiai Parsa
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Medifast stock
What does Medifast do?
Medifast, Inc. is a company in the Consumer Cyclical sector, Personal Products & Services industry, headquartered in United States.
The CEO is Nicholas Johnson, the company employs around 380 people.
The IPO was on 30/12/1993; the stock trades on NYSE under the ticker MED.
What do analysts say about Medifast stock?
12 analysts rate the stock, the consensus is Hold (as of 19/02/2026).
The average price target is US$59.67, ranging from US$12.00 to US$150.00, with a median of US$17.00.
This is an external assessment, not a statement by Market Jury.
When does Medifast report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 59% stronger than usual.
Does Medifast pay a dividend?
Yes. The last dividend was US$1.65 per share, ex-date 18/09/2023, paid on 07/11/2023.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Medifast?
Comparable stocks include Andersen, Amazon.com, Tesla, Home Depot, McDonald's, TJX Companies, Booking Holdings and Lowe's Companies.
How can I get Medifast stock analyzed?
Clicking "Analyze stock" lets five strategies assess Medifast against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.